Skip to content
Bored Studies
RecruitingPhase 1/Phase 2

Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms

U: The Mind Company · NCT07182058

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–80 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 1, Phase 2
Target enrollment
30
US sites recruiting
1
Study start
January 1, 2026
Record last updated
January 27, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study tests a new, non-invasive brain stimulation device called Sphere V3.0 to help improve movement problems in people with Parkinson's disease. The device delivers gentle electrical signals to the scalp using small electrodes placed on the head.

Participants will use the device at home for 13 minutes each weekday (Monday through Friday) for 3 weeks, then be monitored for another 3 weeks without treatment. The entire study lasts 6 weeks and is conducted virtually through video calls and online assessments.

The investigators will measure changes in Parkinson's symptoms using standard rating scales and video recordings of movement tasks like walking and hand tremor tests. Participants will also record videos of their movements at home using their smartphone or computer.

The study includes 30 adults aged 18-80 who have been diagnosed with Parkinson's disease and have stable medication for at least 4 weeks. Participants must have reliable internet access and be able to follow the treatment schedule.

The main goal is to see if this brain stimulation treatment can reduce motor symptoms like tremor, stiffness, and slowness of movement. The investigators will also check if any improvements last after treatment ends and monitor for any side effects.

All participants receive the active device treatment - there is no placebo group. The device has been tested in over 250 people in previous studies with no serious adverse events reported

Being studied: Transcranial Electrical Stimulation Device

Conditions: PARKINSON DISEASE (Disorder)

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Adults 18-80 years with confirmed diagnosis of Parkinson's Disease
  • Hoehn \& Yahr stages 1-4
  • Stable medication regimen for 4+ weeks prior to enrollment
  • Reliable internet access and telehealth capability
  • Ability to provide informed consent
  • Willingness to comply with treatment protocols and follow-up procedures

Exclusion Criteria

  • Metallic head/neck implants (excluding dental fillings)
  • Pregnancy or nursing status
  • Severe skin conditions at electrode placement sites
  • History of epilepsy or seizures (unless technology specifically indicated)
  • Recent stroke or traumatic brain injury (within 6 months)
  • Severe cognitive impairment preventing treatment understanding
  • Any neurological disorders contraindicating transcranial electrical stimulation
  • Current participation in other clinical trials
  • Inability to commit to full treatment and follow-up schedule

Recruiting US locations

  • U LLC Headquarters

    Cleveland, OH 44124

    Site contact: Mohammed h Abouelsoud · mo@uthemind.com

All neurology studies in Ohio →
Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms (NCT07182058) | Bored Studies